RecallRadar

FDA Drug recall D-0287-2019

Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India

On 2018-12-05 the FDA classified a Class II recall of Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India by Ascend Laboratories, citing presence of Foreign Substance; metal shard found in tablet.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0287-2019
ClassificationClass II
Statusterminated
Initiated2018-11-14
Published2018-12-05
Last updated2026-09-13 11:52 UTC
CompanyAscend Laboratories
DistributionUS

Product

Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India. Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 --- NDC 67877-248-01, UPC code: 3 67877-248-01 1

Reason

Presence of Foreign Substance; metal shard found in tablet

Identifiers

upc367877248011
ndc67877-242-01
ndc67877-242-10
ndc67877-242-38
ndc67877-242-33
ndc67877-249-01
ndc67877-249-10
ndc67877-249-38
ndc67877-249-33
ndc67877-250-01
ndc67877-250-38
ndc67877-250-33
ndc67877-250-10
ndc67877-245-01
ndc67877-245-38
ndc67877-245-33
ndc67877-246-01
ndc67877-246-38
ndc67877-246-33
ndc67877-246-10
ndc67877-247-60
ndc67877-247-38
ndc67877-247-33
ndc67877-247-10
ndc67877-248-01
ndc67877-248-38
ndc67877-248-33
ndc67877-248-10
code_infoLot 7143908, exp Nov 2020

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0287-2019%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.